The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest Insights

The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest Insights

Background: The current frequency of hepatitis B virus infection in patients with advanced chronic kidney disease (CKD) (including patients on maintenance dialysis and kidney transplant recipients) is low but not negligible worldwide. HBV has a deleterious effect on survival after a kidney transplan...

Full description

Bibliographic Details
Main Authors:	Fabrizio Fabrizi, Maria Francesca Donato, Federica Tripodi, Anna Regalia, Pietro Lampertico, Giuseppe Castellano
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Pathogens
Subjects:	hepatitis B virus kidney transplantation nucleos(t)ide analogues survival
Online Access:	https://www.mdpi.com/2076-0817/12/2/340

Similar Items

Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies
by: Elisabetta Degasperi, et al.
Published: (2022-10-01)

Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review
by: Faydra I. Lieveld, et al.
Published: (2013-05-01)

Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
by: Young Jip Kim, et al.
Published: (2013-09-01)

The Yin and the Yang of Treatment for Chronic Hepatitis B—When to Start, When to Stop Nucleos(t)ide Analogue Therapy
by: Samuel Hall, et al.
Published: (2020-08-01)

Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
by: Nae-Yun Heo
Published: (2017-06-01)

A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report
by: Sylvia M. Brakenhoff, et al.
Published: (2024-04-01)

Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil
by: Camila V Pereira, et al.
Published: (2016-04-01)

Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy
by: Jin Shang, et al.
Published: (2021-04-01)

Lamivudine: fading into the mists of time
by: Jonggi Choi, et al.
Published: (2017-12-01)

Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
Published: (2011-09-01)

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives
by: Tung-Hung Su, et al.
Published: (2017-09-01)

Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy
by: Meng-Ju Lin, et al.
Published: (2023-07-01)

Current research and challenges of low-level viremia in patients with chronic hepatitis B
by: WANG Jiaojiao, CAI Dachuan
Published: (2024-02-01)

Rapid suppression of HBV replication before related liver transplantation in a patient with HDV superinfection. Clinical case report
by: U. R. Salimov, et al.
Published: (2024-09-01)

Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B
by: Pacheco SR, et al.
Published: (2017-07-01)

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
by: Sang Kyung Jung, et al.
Published: (2015-03-01)

Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients
by: Zhang C, et al.
Published: (2016-03-01)

Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study
by: Yi-Cheng Chen, et al.
Published: (2020-05-01)

Evolution of antiviral treatment chronic for hepatitis B, C and D
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Post-liver transplant HBV infection (Review)
by: A. D. Nikogosova, et al.
Published: (2022-07-01)

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
by: I-Chin Wu, et al.
Published: (2021-05-01)

Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir
by: Juhee Won, et al.
Published: (2022-07-01)

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients
by: Jing Zhao, et al.
Published: (2023-03-01)

Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
by: Xinhui Wang, et al.
Published: (2020-03-01)

The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma
by: Jae Min Park, et al.
Published: (2021-09-01)

Prevention of Hepatitis B Vertical Transmission: Focus on Antenatal Antiviral Administration
by: Anandhara Indriani Khumaedi, et al.
Published: (2016-12-01)

Putative and pretreatment drug resistance mutations in reverse transcriptase gene among untreated chronic hepatitis B patients at Arifin Achmad Regional District Hospital, Riau, Indonesia
by: Arfianti Arfianti, et al.
Published: (2022-05-01)

HBV and HCV Therapy
by: Massimo Colombo, et al.
Published: (2009-10-01)

<i>De novo</i> hepatitis B virus infection after liver transplantation
by: A. D. Nikogosova, et al.
Published: (2022-09-01)

Real-world study on the efficacy and safety of different treatment regimens in treatment-naïve CHB patients with high viral load
by: Xue Wu, et al.
Published: (2024-09-01)

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
by: Jianming Yang, et al.
Published: (2023-01-01)

Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection
by: Fangfang Sun, et al.
Published: (2022-11-01)

The efficacy and safety of addition of pegylated interferon to long-term nucleos(t)ide analogue therapy on functional cure of chronic hepatitis B patient: a systematic review and meta-analysis
by: Xu Zhang, et al.
Published: (2024-10-01)

COLD-PCR Method for Early Detection of Antiviral Drug-Resistance Mutations in Treatment-Naive Children with Chronic Hepatitis B
by: Thuy Thi Bich Phung, et al.
Published: (2020-07-01)

Dynamic Changes in Liver Stiffness in Patients with Chronic Hepatitis B Undergoing Antiviral Therapy
by: Alin Lazar, et al.
Published: (2022-10-01)

Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies
by: Yi-Tse Su, et al.
Published: (2022-08-01)

Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis
by: Yuhao Yao, et al.
Published: (2022-11-01)

Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy
by: Chih-Lin Lin, et al.
Published: (2020-10-01)

Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
by: Margarita Papatheodoridi, et al.
Published: (2020-02-01)

Chronic Hepatitis B Treatment: Current Perspectives on Telbivudine
by: Gian Paolo Caviglia, et al.
Published: (2017-12-01)